Establishing Preventive Cardiology Programs Nathan Wong Nathan Wong.

Slides:



Advertisements
Similar presentations
National Service Frameworks Dr Stephen Newell February 2002.
Advertisements

Organization of Diabetes Care Chapter 6 Maureen Clement, Betty Harvey, Doreen M Rabi, Robert S Roscoe, Diana Sherifali Canadian Diabetes Association 2013.
Introduction Medication non adherence ( noncompliance) remains a major problem. You have to assess and treat adherence related problems that can adversely.
LAKESIDE WELLNESS PROGRAM - PBHCI LEARNING COMMUNITY REGION #3 ORLANDO, FLORIDA, RUTH CRUZ- DIAZ, BSN EXT
Disease State Management The Pharmacist’s Role
The Value of Medication Therapy Management Services
Innovative Pharmacy Services Jann B. Skelton, RPh, MBA Vice President of Operations MEDICA.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
RN SYSTEM WIDE EDUCATION PRESENTED BY S. FERGUSON, T. DILLON, L. LOCK, J. HASBUN, S. SHAH & R. GAINES Shepherd’s Hope.
Medication Therapy Management Linda Mach, PharmD Bartell Drugs Community Practice Resident February 26, 2010.
Clinical Pharmacy II Lobna Al Juffali,MSc Fall-2009.
Ambulatory care Prepared by: Nehad Ahmed. Ambulatory care is Primary care-based services and services provided from office-based specialists and hospital.
Promoting Excellence in Cardiovascular Disease Prevention and Rehabilitation The BACPR Standards and Core Components for Cardiovascular Prevention and.
Prescreening ä To optimize safety ä To permit the development of a sound and effective exercise prescription.
The Role of the Nurse in Implementing CVD Prevention Guidelines Noeleen Fallon Clinical Nurse Specialist in Cardiac Rehabilitation AMNCH, Tallaght, Dublin.
An Overview of the Alberta Screening & Prevention Initiative.
Clinical Pharmacy Basma Y. Kentab MSc..
Quality Improvement Prepeared By Dr: Manal Moussa.
Proposed Cross-center Project Survey of Federally Qualified Health Centers Vicky Taylor & Vicki Young.
Primary Care Psychology Lisa K. Kearney, Ph.D. Primary Care Psychologist South Texas Veterans Health Care System.
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
Rapid E clinical guidance in the management of Type 2 diabetes New Zealand Guidelines Group.
HYPERTENSION The Alabama Department of Public Health’s Hypertension Program.
HOME AND AMBULATORY BLOOD PRESSURE MONITORING
European 4th Joint Task Force on CVD Prevention in Clinical Practice in the context of the National Cardiovascular Health Policy Hannah McGee,
Risk estimation and the prevention of cardiovascular disease SIGN 97.
Pharmacy Services.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Why are we learning this? How scientific knowledge (pharmacology, therapeutics) and clinical skills (measuring blood pressure, glucoses, drug information)
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Quality of care, part 2: heart failure Kim A Eagle MD Albion Walter Hewlett Professor of Internal Medicine Chief, Clinical Cardiology Co-Director, Heart.
Bryan Bray, Pharm.D., CPP Chief Operating Officer Medication Management, LLC Vice President of Clinical Services Piedmont Pharmaceutical Care Network,
The Value of Medication Therapy Management Services.
D-1 Pravastatin-Aspirin Combination The Medical Need Thomas A. Pearson, M.D., Ph.D. Albert D. Kaiser Professor of Community & Preventive Medicine University.
The Athletic Health Care Team
Blood pressure control in primary health care WORKSHOP
Coordinating Care Sierra Dulaney Lisa Fassett Morgan Little McKenzie McManus Summer Powell Jackie Richardson.
Employee health and wellness metrics, measurements, and evaluation - - the building blocks for ROI David A. Alter, M.D., Ph.D., F.R.C.P.C Senior Scientist,
 1. A care plan is developed for each of the patient's medical conditions being managed with pharmacotherapy.  2. A goal of therapy is the desired response.
10 Points to Remember on An Effective Approach to High Blood Pressure ControlAn Effective Approach to High Blood Pressure Control Summary Prepared by Debabrata.
Health Care Reform Primary Care and Behavioral Health Integration John O’Brien Senior Advisor on Health Financing SAMHSA.
Achieving Glycemic Control in the Hospital Setting Part 4 of 4.
The Athletic Health Care Team
Accelerating Reform Initiative Developing Integrated care: Fayette Companies and Heartland Community Health Center Mike Bolye.
Put Prevention Into Practice. Understand the PPIP Program What is Put Prevention Into Practice (PPIP)? What is Put Prevention Into Practice (PPIP)? Why.
Care Management 101 Governor's Office of Health Care Reform October 28, 2010 Cathy Gorski, RN, BS, CCM.
Mental Health Care in the Community Chapter 5. Continuum of Care Ongoing clinical treatment and care matched with intensity of professional health services.
What Does Research Tell Us? Care Manager Roles in Depression Care.
Integration of General Practice in Health services Doris Young Professor of General Practice.
Introduction.
Pharmacists’ Patient Care Process
Using Outcomes and other Assessment Tools to Improve Quality Quality Improvement.
North Rising. Partnership: North Rising is a collaboration between Pillsbury United Communities and North Memorial Health Care.
“Measuring the Units” Alcohol liaison services (ALS) Louise Poley Consultant Nurse in Substance Misuse Cardiff and Vale University Health Board.
Terry McInnis, MD MPH President- Blue Thorn, Inc - Mobile Co-Chair- Center for.
Readmissions Driver Diagram OHA HEN 2.0. Readmissions AIMPrimary Drivers Secondary DriversChange Ideas Reduce Readmissions Identify patients at high-risk.
The Management of People at High Risk of CVD Dr Richard Healicon Mel Varvel NHS Improvement.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Increased # of AI/AN receiving in- home environmental assessment and trigger reduction education and asthma self-management education Increased # of tribal.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
SECONDARY PREVENTION IN HEART DISEASE CATHY QUICK AUBURN UNIVERSITY/AUBURN MONTGOMERY EBP III.
Medical Home Program Care, Compassion, Community.
Clinical Pharmacy II.
The Nursing Process and Pharmacology Jeanelle F. Jimenez RN, BSN, CCRN
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
The Athletic Health Care Team
Pharmaceutical care planning 2 Ola Ali Nassr
Goals & Guidelines A summary of international guidelines for CHD
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

Establishing Preventive Cardiology Programs Nathan Wong Nathan Wong

Cardiac rehabilitation programs exist at some hospitals Effective programs for treating high-risk persons without CVD and long-term programs for persons with established CVD are lacking Well-rounded programs provide professional and community education, research, and clinical management

Components of Programs Cooperation and communication among a wide range of physician and nonphysician health care specialists Mission to deliver effective, efficient, and cost-effective service Components recommended by joint task force include 1) lifestyle and cardiovascular risk assessment, 2) behavioral change, 3) education, 4) family-based intervention, 5) risk-factor management, and 6) screening of first-degree relatives.

Priorities for CHD Prevention Patients with established CHD or other atherosclerotic vascular disease Asymptomatic subjects of particularly high risk (severe dyslipidemia, diabetes, hypertension, multiple risk factors) Close relatives of patients with early-onset CHD Other subjects with one or more cardiovascular risk factors

Identification of Patients at Risk Failure of physicians to request the appropriate tests (e.g., lipid profiles, blood pressure follow-up) or healthcare system to identify those patients needing such tests Few incentives in healthcare system to identify or follow these patients Example: recent chart audit of 50,000 CHD pts showed only 44% to have annual diagnostic testing of LDL-C, and of those tested only 25% reached target LDL-C <100 mg/dl

Estimated Compliance with Secondary Prevention Measures (Pearson et al. 1996) Referral to cardiac rehabilitation <5% Smoking cessation counseling 20% Lipid-lowering drug therapy 25% Beta-blocker therapy 40% ACE inhibitor therapy 60% Aspirin 70%

Tools for CAD Risk Assessment CHD risk algorithms (e.g., Framingham) Questionnaires for nutrition, physical activity, and psychosocial characteristics Use of computerized patient tracking databases to identify patients needing certain tests Reminder checklists for patients with abnormal values needing follow-up or treatment

Key Measures of Quality of Preventive Care (Pearson et al. 1996) Document smoking status in all CHD pts Organizations should have smoking cessation programs Document in medical record use of physician advice and self-help materials to stop smoking All pts with CHD should have fasting lipid profile

Key measures (continued) All patients with CHD who have an LDL-C of 130 mg/dl or higher should be prescribed medication Exercise prescription and counseling should be provided Aspirin should be offered to all patients, or document contradindication All patients should be blood pressures documented at every visit If average of three BP readings are at least 140 mmHg systolic or 90 mmHg diastolic, offer and document lifestyle and pharmacologic management

Recommended Resources Physicians - can provide leadership, ensure prevention is an integral part of the system Nurses - can recruit patients, organize assessments, risk factor screening, etc. Dietitians - provides important dietary management advice Exercise specialists - exercise evaluation and prescriptions Pharmacists - have major educational role in use of drugs, indications, side effects, and increasing role in general health education Psychologists - can design necessary programs to cope and manage stress Vocational Support - assistance may be needed for patients to return to work Facilities - adequate office space, area for assessment, counseling, and education

Organizational Approaches: Office-based approach Many primary care physicians serve as focal point of preventive services delivered in short office visit Physicians can be effective in explaining clinical significance of problem, recommending needed education for risk factor management from other prevention staff Provide protocols for type of specialty services each team member will provide, format, ensure necessary training Suboptimal compliance because –1) not all health professionals agree on strategies, –2) physicians fail to implement risk-reducing therapies, –3) patients poorly adhere to (sometimes because of presumed adverse reactions), and –4) there is lack of adequate reimbursement.

Organizational Approaches: Physician-directed specialty clinic Marketed as a “risk reduction” or “preventive cardiology” clinic May focus on management of a particular disorder such as dyslipidemia or hypertension, but should have capacity for managing other risk factors for “one-stop” preventive care Should be prepared to handle difficult cases First visit may include comprehensive medical history and physical, with battery of diagnostic lab test results, nutrition, exercise, and behavioral survey results available Physician director and other trained physicians, research or administrative director, clinic manager, and other health professionals

Pharmacist or nurse case- management approach Pharmacists or nurse / nurse practitioners taking increasing responsibility for preventive services, assisted by a physician supervisor May be focal point of care in a case-management approach, following lifestyle and/or medical management algorithms, with physician approval of prescriptions Case management systems can be more efficacious and cost- effective than physician-staffed risk factor modification (one nurse-managed home-based program showed greater smoking cessation, lipid control, and improved functional capacity) Patients encouraged to adhere to drug and diet regimens, instructed in self-monitoring, and taught to take appropriate action based on symptoms

Barriers to Implementation Patient factors - lack of knowledge, motivation, access to care, cultural and social factors Physician barriers - focus on “acute care priorities”, pressures of managed care, poor reimbursement, lack of training or confidence in implementing risk-reducing strategies Hospitals often focus on acute conditions, pressure for early discharge, lack of infrastructure and staffing to implement risk-reducing behaviors, and lack of continuity to ensure long-term compliance Often physicians and nurses have no formal training in behavioral aspects of risk factor modification.

Educational Programs Professional - subspecialty training programs should provide instruction on pathophysiologic, epidemiologic, and clinical trial evidence, comprehensive assessment of risk, and techniques to modify risk from lifestyle and pharmacologic means Community Education - lectures, classes, and educational outreach programs to lay public on identifying and reducing risk Research - may include basic, epidemiologic, and/or clinical research programs